Tell your friends about this item:
Development of Gene Therapies: Strategic, Scientific, Regulatory, and Access Considerations - Chapman & Hall / CRC Biostatistics Series
Price
HK$ 2,109
excl. VAT
Ordered from remote warehouse
Expected to be ready for shipping Aug 26 - Sep 7
Our customers say:
Add to your iMusic wish list
Development of Gene Therapies: Strategic, Scientific, Regulatory, and Access Considerations - Chapman & Hall / CRC Biostatistics Series
Development of Gene Therapies: Strategic, Scientific, and Regulatory, and Access Considerations attempts to summarize the current state-of-the-art strategic, scientific, statistical, and regulatory aspects of GTx development.
488 pages, 1 Tables, color; 19 Tables, black and white; 36 Line drawings, color; 1 Line drawings, bl
| Media | Books Hardcover Book (Book with hard spine and cover) |
| Released | May 23, 2024 |
| ISBN13 | 9781032136554 |
| Publishers | Taylor & Francis Ltd |
| Pages | 458 |
| Dimensions | 150 × 220 × 20 mm · 1.07 kg |
| Language | English |
| Editor | McIntosh, Avery (Apellis Pharmaceuticals|Novartis, USA) |
| Editor | Sverdlov, Oleksandr (Apellis Pharmaceuticals|Novartis, USA) |
